Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Adams Bonne J. — Tracon Pharmaceuticals, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Adams Bonne J.

Adams Bonne J.

Chief Operating Officer at Tracon Pharmaceuticals, Inc. · on record since Feb 9, 2023

Insider trading activity of Adams Bonne J.

Transactions on record: 1; since Feb 9, 2023

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Feb 9, 2023

Figures computed from official regulatory filings — methodology.

Companies where Adams Bonne J. has traded

Tracon Pharmaceuticals, Inc.1 tx · Feb 9, 2023

Track record of Adams Bonne J.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Adams Bonne J.

Co-insiders of Adams Bonne J.

BARRETT M JAMESTracon Pharmaceuticals, Inc.
BARRIS PETER JTracon Pharmaceuticals, Inc.
BASKETT FORESTTracon Pharmaceuticals, Inc.
BITAR PATRICIA LTracon Pharmaceuticals, Inc.
Brookline Tracon Investment Fund II, LLCTracon Pharmaceuticals, Inc.
BROOKLINE TRACON INVESTMENT FUND LLCTracon Pharmaceuticals, Inc.
Brown Scott B.Tracon Pharmaceuticals, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

CSA Biotechnology Fund II, LLCTracon Pharmaceuticals, Inc.

CSA Biotechnology Fund I, llcTracon Pharmaceuticals, Inc.

DRANT RYAN DTracon Pharmaceuticals, Inc.

Florence Anthony A. Jr.Tracon Pharmaceuticals, Inc.

Harada KenjiTracon Pharmaceuticals, Inc.

Hozoji HironoriTracon Pharmaceuticals, Inc.

JAFCO Super V3 Investment Limited PartnershipTracon Pharmaceuticals, Inc.

Johnson-Pratt LisaTracon Pharmaceuticals, Inc.

KERINS PATRICK JTracon Pharmaceuticals, Inc.

KOLLURI KRISHNA KITTUTracon Pharmaceuticals, Inc.

Lam Carol C.Tracon Pharmaceuticals, Inc.

LARUE WILLIAM RTracon Pharmaceuticals, Inc.

Lazar David E.Tracon Pharmaceuticals, Inc.

LOGAN H CASEYTracon Pharmaceuticals, Inc.

MATTINGLY MARTIN ATracon Pharmaceuticals, Inc.

MOTT DAVID MTracon Pharmaceuticals, Inc.

NEA 14 GP, LTDTracon Pharmaceuticals, Inc.

NEA Partners 14, L.P.Tracon Pharmaceuticals, Inc.

New Enterprise Associates 14, L.P.Tracon Pharmaceuticals, Inc.

Opaleye Management Inc.Tracon Pharmaceuticals, Inc.

PELLETIER SAUNDRA LTracon Pharmaceuticals, Inc.

Puissance Capital Fund (GP) LLCTracon Pharmaceuticals, Inc.

Puissance Capital Management (GP) LLCTracon Pharmaceuticals, Inc.

Puissance Capital Management LPTracon Pharmaceuticals, Inc.

Puissance Cross-Border Opportunities IV LLCTracon Pharmaceuticals, Inc.

Puissance Cross-Border Opportunities V LLCTracon Pharmaceuticals, Inc.

Puissance Life Science Opportunities Fund VITracon Pharmaceuticals, Inc.

SANDELL SCOTT DTracon Pharmaceuticals, Inc.

SHAZER RONALD LTracon Pharmaceuticals, Inc.

Sonsini Peter W.Tracon Pharmaceuticals, Inc.

THEUER CHARLESTracon Pharmaceuticals, Inc.

Twiford J RainerTracon Pharmaceuticals, Inc.

Viswanathan RaviTracon Pharmaceuticals, Inc.

Walker Paul EdwardTracon Pharmaceuticals, Inc.

Wang Theodore TTracon Pharmaceuticals, Inc.

Weller Harry RTracon Pharmaceuticals, Inc.

WIGGINS MARK CTracon Pharmaceuticals, Inc.

WORLAND STEPHEN TTracon Pharmaceuticals, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Tracon Pharmaceuticals, Inc.	Feb 9, 2023	AwardD	99,000	0.00 USD	$0	SEC